SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
        • The Outperformers (91-100)

          These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

          September 10, 2019
        • New growth model

          Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?

          Kripa Mahalingam - July 26, 2019
        • Opportunistic Buyer

          Sailesh Raj Bhan has made optimum use of cyclical downturns to deliver outperformance

          Khushboo Balani - January 25, 2018
        • Is the worst over for pharma stocks?

          The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues 

          July 17, 2017
        • Oh No! Aurobindo

          The recent negative news flow has led to a selling spree in Aurobindo Pharma

          Jash Kriplani - January 24, 2017
        • Good Timing

          Aurobindo Pharma promoters sell over 10 million shares in a market transaction valued at Rs.900 crore

          Jitendra Kumar Gupta - October 14, 2016
        • Self-healing

          Hyderabad’s pharma players are adapting to a regulatory backlash and fighting back against dumping from China

          Krishna Gopalan - March 09, 2016
        • Overdosing on growth

          A shift in focus in the US and the EU has propelled the stock price of Aurobindo Pharma to an all-time high

          Adit Mathai - April 20, 2015

        Latest Edition

        magcover
        June 01, 2023
        magcover
        May 01, 2023
        magcover
        April 01, 2023
        magcover
        March 01, 2023
        twitterlinkedininstagramUser Profile
        • BIG STORY
        • PERSPECTIVE
        • ENTERPRISE
        • STRATEGY
        • MARKETS
        • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C'EST LA VIE
        • MAGAZINE
        About us Contact usPrivacy PolicyTerms and ConditionsSitemap
        Copyright © 2019 Outlook Business!. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.